EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 3b

Ensembl ID : ENSOTSG00005038532
Gene Symbol: ATP1B3B
1 Cross references
226 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSOTSG00005008040
Gene Symbol: AXL
2 Cross references
184 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSOTSG00005003950
Gene Symbol: BCL2
1 Cross references
170 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSOTSG00005046080
Gene Symbol: BCL2
1 Cross references
170 Possible Orthologues:

Bcl2 Apoptosis Regulator A

Ensembl ID : ENSOTSG00005013863
Gene Symbol: BCL2A
1 Cross references
160 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOTSG00005017010
Gene Symbol: BCL2L1
1 Cross references
220 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOTSG00005043147
Gene Symbol: BCL2L1
3 Cross references
215 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOTSG00005026349
Gene Symbol: BCL2L1
3 Cross references
215 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSOTSG00005039880
Gene Symbol: BCR
1 Cross references
198 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSOTSG00005043808
Gene Symbol: BCR
1 Cross references
199 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSOTSG00005023374
Gene Symbol: BTK
1 Cross references
202 Possible Orthologues:

C-C Chemokine Receptor Type 9-Like

Ensembl ID : ENSOTSG00005036539
Gene Symbol: LOC112215705
2 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).